Status:
UNKNOWN
A Multicenter Clinical Study of rTMS for Parkinson's Disease
Lead Sponsor:
Affiliated Hospital of Nantong University
Conditions:
Parkinson's Disease
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
Through rTMS, motor dysfunction and non-motor dysfunction of PD patients can be improved, working and living ability and quality of life of patients can be improved, and social burden and family burde...
Detailed Description
According to the inclusion criteria, a total of 200 patients with Parkinson's disease were planned to be enrolled in each center, and randomly divided into control group (conventional treatment) and o...
Eligibility Criteria
Inclusion
- Hoehn-YAHR classification is between 1 and 2；
- Have a primary school education or above and can read the scale used in this study;
- MoCA score between 20 and 24, mild cognitive impairment ;
- Aged between 30 and 80, regardless of gender；
- Voluntarily participate and sign informed consent.
Exclusion
- patients with cerebrovascular accident, craniocerebral injury and other diseases affecting muscle tension;
- patients with serious mental disorders and cognitive disorders who cannot cooperate with assessment;
- patients with severe liver, kidney, heart dysfunction and severe physical disorders;
- Implanted devices such as pacemakers are installed inside the body;
- drug-induced Parkinson's syndrome or Parkinson's superposition syndrome;
- Have a history of epilepsy;
- Women during pregnancy and breastfeeding.
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06009471
Start Date
July 1 2023
End Date
August 1 2025
Last Update
August 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
rTMS
Nantong, Jiangsu, China, 226001